5/10/2004

Eli Lilly will be watching closely this week while British regulators decide whether to make the company's Prozac the first anti-depressant drug approved in the U.K. for children, as it is in the U.S. The U.K. regulators have had their eye on fluoxetine, the generic name of Prozac, for nearly a year as one drug for youths that would not lead them to consider suicide and one in which the benefits outweigh the risks.

Related Summaries